Mutation Analysis in Chronic Myeloid Leukemia (CML)
0 Visualizzazioni
• 06/27/23
0
0
Incorporare
administrator
Iscritti
The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; Harry Erba, MD, PhD; Javier Pinilla-Ibarz, MD, PhD; and David Snyder, MD, FACP, explain technological advances in mutation analysis for chronic myeloid leukemia (CML).
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti